NASDAQ:OACC · NASDAQ Global Market
+$0.00 today
Vol 0.00M · Avg 0.01M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Management quality matters because capital allocation choices determine how much of Oaktree Acquisition Corp. III Life Sciences earnings power becomes long-term shareholder value. Use this page to compare OACC returns on capital, executive context, insider transactions, ownership signals, and growth trends against peers, then decide whether leadership appears disciplined, aligned, and capable of compounding through changing market conditions.
Return Metrics
ROE, ROIC & ROA over time
ROE
3.7%
avg 1.9%
ROIC
-0.6%
avg -0.3%
ROA
3.6%
avg 1.8%
Analysis
ROE is currently the strongest return metric at 3.7% versus its period average of 1.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
George A. Martinez | Chief Financial Officer, Principal Accounting & Principal Financial Officer | — | — | 41 | $0.00 | <0.01% |
Mathew Pendo | Chief Operation Officer | — | — | 62 | — | — |
Zaid Pardesi | Chief Executive Officer & Director | — | — | 43 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A — |
| Revenue | N/A | N/A | N/A | N/A — |
| Net Income | N/A | N/A | N/A | N/A — |
| EBIT | N/A | N/A | N/A | N/A — |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
Cartesian Growth Corporation III
NASDAQ:CGCT
$399.10M
M3-Brigade Acquisition V Corp.
NASDAQ:MBAV
$389.20M
Artius II Acquisition Inc. Class A Ordinary Shares
NASDAQ:AACB
$291.14M
Soulpower Acquisition Corp.
NYSE:SOUL
$265.69M
Perimeter Acquisition Corp. I Class A Ordinary Shares
NASDAQ:PMTR
$259.03M
FACT II Acquisition Corp
NASDAQ:FACT
$258.54M
Rithm Acquisition Corp.
NYSE:RAC
$248.67M
Copley Acquisition Corp
NYSE:COPL
$247.96M
Mountain Lake Acquisition Corp. Class A
NASDAQ:MLAC
$30.37M
Who manages OACC?
Oaktree Acquisition Corp. III Life Sciences (OACC) lists 3 active executives. The top listed executive is George A. Martinez, Chief Financial Officer, Principal Accounting & Principal Financial Officer.
Are OACC insiders buying or selling?
Recent insider activity shows net buying of $339,810.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.